Results 51 to 60 of about 30,534 (142)

Risk of cancer after assisted reproduction: a review of the available evidences and guidance to fertility counselors [PDF]

, 2018
Infertile women requiring ovarian stimulation and assisted reproduction techniques (ART) are faced with difficult issues. The fear that using hormones could increase their risk of cancer is the most significant.
Codacci-Pisanelli, G, Del Pup, L, Levi-Setti, P E, Patrizio, P, Peccatori, F A   +4 more
core   +1 more source

Nanomedicine Approaches for Autophagy Modulation in Cancer Therapy

Small Science, EarlyView.
Autophagy modulation holds promise for enhancing cancer treatment, yet clinical translation remains challenging. This review explores nanomedicine‐based strategies to improve autophagy‐targeting drugs, highlighting their synergy with chemotherapy, immunotherapy, phototherapy, and gene therapy. It also discusses nanoparticle design and clinical progress,
Sohaib Mahri, Rodolfo Villa, Ya‐Ping Shiau, Menghuan Tang, Kelsey Jane Racacho, Qiufang Zong, Saiful Islam Chowdhury, Tan Hua, Felipe Godinez, Andrew Birkeland, Tzu‐Yin Lin, Yuanpei Li   +11 more
wiley   +1 more source

Real-time virtual sonography in gynecology & obstetrics. literature's analysis and case series [PDF]

, 2018
Fusion Imaging is a latest generation diagnostic technique, designed to combine ultrasonography with a second-tier technique such as magnetic resonance imaging and computer tomography.
Bellati, F, Caserta, D., Costanzi, Flavia, DE MARCO, MARIA PAOLA, Manurita, F, Taloni, Enrica, Torcia, F   +6 more
core   +1 more source

Exosome‐Based Theranostic for Gastrointestinal Cancer: Advances in Biomarker Discovery and Therapeutic Engineering

Small Methods, EarlyView.
This review explores the dual roles of exosomes in gastrointestinal (GI) cancers as diagnostic biomarkers and therapeutic agents. It highlights advancements in exosomal miRNAs, lncRNAs, circRNAs, and proteins for cancer detection and prognosis. The study also examines engineering strategies for exosome‐based drug delivery systems, their potential to ...
Mohit J. Mehta, Dongjun Shin, Hyun Sung Park, Jun Su An, Seong Il Lim, Hyun Jin Kim, Seungpyo Hong, Jiyoon Bu   +7 more
wiley   +1 more source

Evasion of anti-growth signaling: a key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds [PDF]

, 2015
The evasion of anti-growth signaling is an important characteristic of cancer cells. In order to continue to proliferate, cancer cells must somehow uncouple themselves from the many signals that exist to slow down cell growth.
A.R.M. Ruhul Amin, Abraham, Adorno, Ahmad, Akhurst, Alan Bilsland, Albertoni, Alexandros G. Georgakilas, Amedeo Amedei, Amin, Amin, Amin, Amr Amin, Apelqvist, Arbiser, Aronchik, Asfar S. Azmi, Aster, Athar, Baek, Baek, Baek, Baek, Bagli, Bahr, Balasubramanyam, Banerjee, Barry, Bateman, Bauskin, Bean, Beckerman, Belletti, Berletch, Bhattacharyya, Bian, Bill Helferich, Bock, Bolos, Bolos, Bootcov, Bracken, Bray, Bray, Breen, Brooks, Brown, Brown, Brown, Buck, Bunney, Cancer Genome Atlas Research, Cantero, Cekanova, Chandra S. Boosani, Charles, Chen, Chen, Chen, Chen, Chen, Chen, Chen, Chen, Chen, Chen, Chen, Chen, Chen, Chen, Chen, Chen, Cheng, Chintharlapalli, Choi, Choudhuri, Christofori, Classon, Clem, Cordero-Espinoza, Cornen, Costa, Covey, Cui, Dai, Dai, Dallas, Damera, Dameron, Daniels, Dardousis, Debeb, Decristofaro, Dell’Eva, Deng, Denissova, Dennis, Dhar, Di, Dickinson, Dickson, Ding, Dipita Bhakta, Dominguez, Dong, Dong M. Shin, Dorota Halicka, Dotsch, Douc-Rasy, Du, Dudas, Durfort, D’Angelo, Ehebauer, Elena Niccolai, Enderle, Engelman, Evans, Fang, Fang, Farabegoli, Faridoni-Laurens, Fernandez, Firth, Fischbach, Fotsis, Fox, Freed-Pastor, Friday, Fuggetta, Gabellini, Gao, Garcia, Garofalo, Gazala N. Khan, Giovannini, Gloria S. Huang, Goldstein, Griner, Grogan, Gualberto, Guan, Guan, Gudkov, Guha, Gui, Gullett, Guo, Guo, Guo, Guo, Gupta, Haddad, Hahm, Hahm, Hahn, Hald, Hanahan, Hardcastle, Hardtner, Harper, Hartog, Harvey, Hastak, Hayes, Heallen, Hebert, Hendrickson, Hennessy, Herman-Antosiewicz, Heyninck, Heyninck, Hiromasa Fujii, Ho-Young Lee, Hoffmann, Hollander, Holy, Hossain, Huang, Huang, Huang, Hudson, Humbel, Husaini, Hussain, Hwa, Ichimiya, Indovina, Ishida, Jack Arbiser, Jacque, Jang, Jerome, Ji, Jia, Jiang, Jin-Tang Dong, Joerg Reichrath, Jogie-Brahim, Johnson, Jones, Joshi, Jung, Kahlert, Kan, Kang, Kanya Honoki, Karpowicz, Katagiri, Katia Aquilano, Kaushik, Kennedy, Khan, Khaw, Khaw, Kim, Kim, Kim, Kim, Kim, Kim, Kim, King, Knudsen, Knuutila, Koduru, Kohno, Kong, Konishi, Kooijman, Koopmann, Koopmann, Kopelovich, Kovalev, Kunnumakkara, Kurosu, Kwak, Lai, Lam, Lamar, Lambert, Lamonte, Lanzilli, Leao, Lee, Lee, Lee, LeRoith, Leupin, Levine, Li, Li, Li, Li, Li, Li, Liang, Lichner, Licitra, Lin, Lin, Lin, Lindmark, Liu, Liu, Liu, Liu-Chittenden, Loukopoulos, Lundberg, Luo, Luo, Ma, Maher, Maillard, Majumdar, Malaguarnera, Mamo, Mankame, Maor, Maria Rosa Ciriolo, Martinez, Martinez-Garcia, Massi, Maxwell, McClatchey, McGrath, Medema, Mendivil, Menendez, Miele, Mimeault, Min, Mitra, Miyake, Miyamoto, Mizuno, Mohan, Moll, Moon, Moore, Morgillo, Murga, Murillo, Murtaugh, Nagl, Nahta, Nair, Nakamura, Nallet-Staub, Nandakumar, Nandan, Nandan, Nandan, Nasiri, National Cancer Genome Atlas Research, Nefedova, Negi, Ng, Nian, Nihal, Ogawara, Oh, Oh, Okuyama, Omer Kucuk, Ono, Osada, Ouchi, Overholtzer, Pal, Pankov, Park, Park, Peacock, Phillip A. Karpowicz, Pinnix, Pollak, Pollak, Ponnurangam, Pons, Pratheeshkumar, Premkumar, Rao, Reed, Reedijk, Reedijk, Reidy, Reinmuth, Reisman, Ren, Riedemann, Rita Nahta, Rizzo, Rogler, Rosenfeldt, Roy, Rufini, Ryan, S. Salman Ashraf, Sadava, Samani, Santer, Santoro, Sarkar, Sasiela, Sausen, Schlegelmilch, Schmidt, Selander, Senapati, Serrano, Shamim, Shammas, Shangary, Shankar, Shankar, Sharif, Sharma, Shi, Shih Ie, Shijun Mi, Shim, Shim, Shimizu, Shin, Shindo, Shnaper, Shrimali, Siddiqui, Singh, Sinha, Sjolund, Somaira Nowsheen, Sophie Chen, Sotoca, Staal, Staff, Stockhausen, Stoeltzing, Stupack, Su, Subbaramaiah, Suh, Sulma I. Mohammed, Sun, Sunahara, Sur, Szarc vel Szic, Tan, Tan, Tannapfel, Tao, Thaiparambil, Thamilselvan, Thomas E. Carey, Tian, Ting, Trimboli, Tsui, Ulanet, Ulbricht, Valenti, van der Veeken, Vanhara, Varelas, Varelas, Villanueva, Volate, Vousden, W. Nicol Keith, Wallace, Wallin, Wang, Wang, Wang, Wang, Wang, Wang, Wang, Wang, Wang, Wang, Wang, Wang, Wang, Wang, Wang, Weinberg, Welsh, Wen, Weng, Werner, Werner, Wesolowska, Wetterau, Whitson, Wiegand, Wiklund, William, Wilson, Wolf, Wong, Wu, Wu, Wu, Wynne, Xie, Xing, Xu, Xue, Xujuan Yang, Yamaguchi, Yamamoto, Yan, Yang, Yang, Yang, Yasaei, Yavari, Yee, Yin, Ying, Yokomizo, Yokomizo, Yonekura, Youns, Yu, Yu, Yu, Yu, Zaika, Zang, Zanotto-Filho, Zender, Zgheib, Zhang, Zhang, Zhang, Zhang, Zhang, Zhang, Zhang, Zhang, Zhang, Zhang, Zhang, Zhao, Zhao, Zhao, Zheng, Zheng, Zhong, Zhu, Zhuo G. Chen, Zilfou, Zlotogorski   +515 more
core   +1 more source

Unveiling the complex extra‐oral colonization pathways and pathogenic mechanisms of Fusobacterium nucleatum, a heterogeneous oral pathogen

VIEW, EarlyView.
We summarize the taxonomic characteristics, capabilities to adhere to and invade host cells, extra‐oral ectopic colonization pathways, and major pathogenic mechanisms of Fusobacterium nucleatum, and explore the regulation of F. nucleatum’s pathogenesis, aiming to provide references and assistance for the development of clinical interventions and future
Zhiwei Guan, Houbao Qi, Qiang Feng
wiley   +1 more source

Androgen receptor expression in human ovarian and uterine tissue of long term androgen-treated transsexual women [PDF]

, 1994
Androgen receptor (AR) modulation in human uteri and ovaries of long term androgen-treated transsexual female patients was investigated. Androgen receptor expression was evaluated immunohistochemically in the ovaries of 11 and the endometria and ...
Brinkmann, A.O. (Albert), Chadha, D., Huikeshoven, F.J. (Frans), Kwast, Th.H. (Theo) van der, Pache, T.D.   +4 more
core   +2 more sources

The Demographics and Outcomes of Women With Stage II Endometrial Cancer Diagnosed in Australia 2005–2007

Australian and New Zealand Journal of Obstetrics and Gynaecology, EarlyView.
ABSTRACT Background Stage II endometrial cancer comprises 5% to 10% of cases and is pathologically diverse. Retrospective data guides recommendations which suggest surgical staging with adjuvant therapy, but the role of radical surgery and lymphadenectomy is uncertain, due to conflicting outcomes.
Jonathan Sandeford, Pearl Tong, Selvan Pather   +2 more
wiley   +1 more source

Advances in breast cancer treatment and prevention: preclinical studies on aromatase inhibitors and new selective estrogen receptor modulators (SERMs). [PDF]

, 2003
Intensive basic and clinical research over the past 20 years has yielded crucial molecular understanding into how estrogen and the estrogen receptor act to regulate breast cancer and has led to the development of more effective, less toxic, and safer ...
Brown, Powel H, Chamness, Gary C, Schiff, Rachel   +2 more
core   +2 more sources

Natural products targeting tumour angiogenesis

British Journal of Pharmacology, Volume 182, Issue 10, Page 2094-2136, May 2025.
Abstract Tumour angiogenesis is the formation of new blood vessels to support the growth of a tumour. This process is critical for tumour progression and metastasis, making it an attractive approach to cancer therapy. Natural products derived from plants, animals or microorganisms exert anti‐angiogenic properties and can be used to inhibit tumour ...
Xiaohua Lu, Lara Johanna Friedrich, Thomas Efferth   +2 more
wiley   +1 more source